Detalles de la búsqueda
1.
Pharmacogenomic study-A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention.
Pharmacogenomics J
; 24(3): 11, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594235
2.
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study.
Headache
; 64(6): 663-673, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38700250
3.
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse.
J Headache Pain
; 25(1): 26, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38408888
4.
Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States.
BMC Neurol
; 23(1): 158, 2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37081405
5.
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.
Headache
; 63(2): 264-274, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633219
6.
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
J Headache Pain
; 24(1): 155, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985968
7.
Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injury.
Headache
; 62(6): 726-736, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670213
8.
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
J Headache Pain
; 23(1): 115, 2022 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068494
9.
Real-world efficacy, tolerability, and safety of ubrogepant.
Headache
; 61(4): 620-627, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547676
10.
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
Headache
; 61(1): 125-136, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33314079
11.
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.
Headache
; 61(9): 1421-1431, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551130
12.
A pilot exploratory study comparing the King-Devick test (KDT) during and between migraine attacks.
Cephalalgia
; 40(3): 307-312, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31660762
13.
E-Consultation in Headache Medicine: A Quality Improvement Pilot Study.
Headache
; 60(10): 2192-2201, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063855
14.
Pressing Issues Among Trainees and Early Career Physicians in Headache Medicine: Survey Results From the American Headache Society New Investigator and Trainee Section and International Headache Academy.
Headache
; 60(4): 745-751, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32030744
15.
Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.
Headache
; 60(9): 2014-2025, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920850
16.
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
Headache
; 60(10): 2304-2319, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249580
17.
COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
Headache
; 60(8): 1558-1568, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648592
18.
Advocacy in Headache Medicine: Tips at the Bedside, the Institutional Level, and Beyond.
Curr Neurol Neurosci Rep
; 20(11): 52, 2020 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940800
19.
Noninvasive Neuromodulation in Migraine.
Curr Pain Headache Rep
; 24(12): 78, 2020 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326063
20.
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.
J Headache Pain
; 20(1): 90, 2019 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464581